Détention brevets de la classe A61K 39/00

Brevets de cette classe: 47867

Historique des publications depuis 10 ans

3072
3637
4090
4006
3894
3963
3411
2774
4650
2119
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
Immatics Biotechnologies GmbH
1152
888
The Regents of the University of California
19784
564
Regeneron Pharmaceuticals, Inc.
4211
546
The Trustees of the University of Pennsylvania
4295
505
Glaxosmithkline Biologicals S.A.
1635
489
The United States of America, as represented by the Secretary, Department of Health and Human Services
2832
464
Genentech, Inc.
3935
459
Novartis AG
10963
425
Janssen Biotech, Inc.
1518
310
The Board of Trustees of the Leland Stanford Junior University
6329
306
Amgen Inc.
4024
303
Memorial Sloan-Kettering Cancer Center
1901
298
Board of Regents, The University of Texas System
5738
273
Hoffmann-La Roche Inc.
3357
267
Inserm (institut National de La Sante et de La Recherche Medicale)
3358
256
Bristol-myers Squibb Company
4896
253
Dana-Farber Cancer Institute, Inc.
2545
249
Pfizer Inc.
3352
230
The General Hospital Corporation
4700
201
The Johns Hopkins University
5628
200
Autres propriétaires 40381